PreprintAll rights reservedmedRxiv
Formal dissent in CHMP opinions on new medicines, 2020-2025
- 1Harvard-MIT Center for Regulatory Science
Related
- Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing
- Workers' opinions on working time regulations: results from the 5th Korean Work, Sleep, and Health Study (KWSHS)
- "I live my own life": relationship between will to live and wish to die in nursing home residents and their opinions about actions to promote their will to live.
- Could Climate Change Be Silently Damaging Medicines We Keep at Home?
- The Role of Herbal Medicines in Cognitive Impairment: A Narrative Review of Neuroprotective Mechanisms and Therapeutic Perspectives
BibTeX
@misc{siebert2026formal,
title = {{Formal dissent in CHMP opinions on new medicines, 2020-2025}},
author = {M. Siebert and A. Tibau},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.03.26367215},
url = {https://www.medrxiv.org/content/10.64898/2026.11.03.26367215v1},
}
RIS
TY - UNPB
TI - Formal dissent in CHMP opinions on new medicines, 2020-2025
AU - M. Siebert
AU - A. Tibau
PY - 2026
DA - 2026/11/03
PB - medRxiv
DO - 10.64898/2026.11.03.26367215
UR - https://www.medrxiv.org/content/10.64898/2026.11.03.26367215v1
ER -